Until today, the most definitive theory about the Mets signing Matt Harvey to a long-term contract extension was the prevailing belief his agent Scott Boras would play the market and hold out for the last dollar. We concluded this based in large part by what Harvey said last year during his innings fiasco when he said he hired Boras to take care of his career.
Harvey said today what we already knew, that the Mets hadn’t opened negotiations and don’t even have a timetable of doing so.
Harvey, who is under Mets’ control until after the 2018 season and will make $4.325 million this season, today said he’s not ruling out anything. He said he was open for discussion, but don’t forget spring training hasn’t started yet and Boras is still in the equation.
“I think whatever comes up is going to come up,” Harvey told reporters today in Port St. Luice. “I’ve never shied away from it. I’ve never said I wouldn’t consider it. But I haven’t heard anything considering that.”
Jacob deGrom has been more open about his willingness to sign a long-term extension, which is why I recently wrote he should be the Mets’ first choice, followed by Noah Syndergaard and Steven Matz before Harvey. The reason for Harvey being down on the list was the presumption Harvey wasn’t interested because of Boras.
Zack Wheeler will be a free agent after 2019 season, with deGrom eligible after 2020, followed by Syndergaard and Matz after 2021.
Harvey will be arbitration eligible for the next two years, so his salary will continue to spike assuming he remains healthy and pitches to expectations. The 26-year-old Harvey was 13-8 with a 2.71 ERA in 29 starts, and despite the innings issue he logged 216 innings, which included the playoffs.
Traditionally, pitchers recovering from Tommy John surgery – Harvey had his in 2013 and missed all of 2014 – and with no innings limits projected for this season, there’s reason for optimism. Assuming the Mets can sign Harvey to a three-year deal, that would cover two arbitration years and his first season of free-agent eligibility.
There’s risk, of course, but if he stays healthy and produces it is a win-win for the Mets. Considering there’s the rest of the rotation to consider and several high-salaried Mets could be off the books over the next few years, this could be the time to act.